Sheng Xu

Prof. Sheng Xu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2014 in Science
Verified
Journal Article
Closed access
PDF file
PWPin Wang
Pin Wang
YXYiquan Xue
Yiquan Xue
YHYanmei Han
Yanmei Han
LLLi Lin
Li Lin
CWCong Wu
Cong Wu
XCXuetao Cao
Xuetao Cao
L[i]nc to Dendritic Cell Activation: Long noncoding RNAs (lncRNAs) are important regulators of gene expression, but whether they are important regulators of the immune system is poorly understood. Wang et al. (p. 310 ) identify a lncRNA expressed exclusively in human dendritic cells (DC), called lnc-DC, that is required for optimal DC differentiation from human monocytes and that regulates DC activation of T cells. Lnc-DC interacts with the transcription factor STAT3, which is also required for DC development and function, to prevent interaction with and to block dephosphorylation by tyrosine phosphatase SHP1.

24 July 2011 in Nature Immunology
Verified
Journal Article
Closed access
FMFeng Ma
Feng Ma
SXSheng Xu
Sheng Xu
XLXingguang Liu
Xingguang Liu
QZQian Zhang
Qian Zhang
XXXiongfei Xu
Xiongfei Xu
XCXuetao Cao
Xuetao Cao

18 July 2010 in Nature Immunology
Verified
Journal Article
Closed access
CHChaofeng Han
Chaofeng Han
JJJing Jin
Jing Jin
SXSheng Xu
Sheng Xu
HLHaibo Liu
Haibo Liu
NLNan Li
Nan Li
XCXuetao Cao
Xuetao Cao

12 April 2010 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
SXSheng Xu
Sheng Xu
XCXuetao Cao
Xuetao Cao

13 January 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JCJie Chen
Jie Chen
LCLikun Cui
Likun Cui
SLShaoteng Lu
Shaoteng Lu
SXSheng Xu
Sheng Xu
Amino acid metabolism plays important roles in tumor biology and tumor therapy. Accumulating evidence has shown that amino acids contribute to tumorigenesis and tumor immunity by acting as nutrients, signaling molecules, and could also regulate gene transcription and epigenetic modification. Therefore, targeting amino acid metabolism will provide new ideas for tumor treatment and become an important therapeutic approach after surgery, radiotherapy, and chemotherapy. In this review, we systematically summarize the recent progress of amino acid metabolism in malignancy and their interaction with signal pathways as well as their effect on tumor microenvironment and epigenetic modification. Collectively, we also highlight the potential therapeutic application and future expectation.

1 June 2012 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
LLLihua Lai
Lihua Lai
QCQingyun Chen
Qingyun Chen
YSYinjing Song
Yinjing Song
SXSheng Xu
Sheng Xu
QWQingqing Wang
Qingqing Wang
Myeloid-derived suppressor cells (MDSCs) potently suppress the anti-tumor immune responses and also orchestrate the tumor microenvironment that favors tumor angiogenesis and metastasis. The molecular networks regulating the accumulation and functions of tumor-expanded MDSCs are largely unknown. In this study, we identified microRNA-494 (miR-494), whose expression was dramatically induced by tumor-derived factors, as an essential player in regulating the accumulation and activity of MDSCs by targeting of phosphatase and tensin homolog (PTEN) and activation of the Akt pathway. TGF-β1 was found to be the main tumor-derived factor responsible for the upregulation of miR-494 in MDSCs. Expression of miR-494 not only enhanced CXCR4-mediated MDSC chemotaxis but also altered the intrinsic apoptotic/survival signal by targeting of PTEN, thus contributing to the accumulation of MDSCs in tumor tissues. Consequently, downregulation of PTEN resulted in increased activity of the Akt pathway and the subsequent upregulation of MMPs for facilitation of tumor cell invasion and metastasis. Knockdown of miR-494 significantly reversed the activity of MDSCs and inhibited the tumor growth and metastasis of 4T1 murine breast cancer in vivo. Collectively, our findings reveal that TGF-β1–induced miR-494 expression in MDSCs plays a critical role in the molecular events governing the accumulation and functions of tumor-expanded MDSCs and might be identified as a potential target in cancer therapy.